Clinical and Laboratory Standards Institute (CLSI) guideline EP09-A3, 9 and the recently proposed Food and Drug Administration (FDA) Draft Guidance for over-the-counter SMBG systems. 10 In most of these examples, testing of more than 1 reagent system lot is required or at least encouraged to account for lot-to-lot variability. However, the guidelines differ with respect to procedural recommendations or requirements and the minimum accuracy criteria specified.
Results obtained from such accuracy assessments are often visualized in difference plots, such as, for example, recommended by ISO 15197, or in regression plots. However, such plots become more difficult to read as the number of data points displayed increases. A new approach, the rectangle target plot (RTP), was presented by Stephan and colleagues. 11 In RTP, a single rectangle is created based on measurement data from any number of measurements. Thus, it enables data from different systems or from different reagent system lots to be displayed in the same graph, while the graph remains comprehensible.
In the analysis presented here, RTPs were created for a total of 50 different SMBG systems and 87 different reagent system lots from 8 different manufacturers.
Methods
Data from different system accuracy evaluations following ISO 15197, 4, 5 were retrospectively analyzed by creating RTPs. 11 The evaluations were performed between 2008 and 2014 at the Institut für Diabetes-Technologie Forschungsund Entwicklungsgesellschaft mbH at the University of Ulm, Germany. Nearly 80% of the system accuracy results have been published. [12] [13] [14] [15] [16] [17] The objective of the analysis was to evaluate performance characteristics of SMBG systems per manufacturer. Therefore the analysis presented here is limited to manufacturers from which at least 3 different products were evaluated. A maximum number of products per manufacturer was not defined.
RTPs were created by calculating tolerance intervals for BG concentrations <100 mg/dL and ≥100 mg/dL that cover 90% of data points with a confidence of 95%, as described by Stephan and colleagues. 11 These calculations were performed for each reagent system lot separately. As described by Stephan and colleagues, 11 the basic assumption for the RTP is that the data are normally distributed. In the case of a strong deviation from normal distribution due to outliers, tolerance intervals were calculated based on robust estimators such as the median and the scale estimator S n , and checked for consistency with the observed distribution of measurement data. 18 However, due to excessive skewness of data, even the robust estimators can be biased. In these cases, the rectangles were calculated using robust estimators but marked with dashed lines as the size of the rectangles may not fully correspond to real assessment data.
Results
A total of 87 different reagent system lots from 8 different manufacturers were included in the analysis. If data were available for multiple reagent system lots of a specific system, all lots were included. The analysis inclusion criteria were met by products from Abbott Diabetes Care (Figure 1 (Figure 9 ). Although an important benefit of the RTP is the ability to illustrate several lots or products in 1 graph, the large number of data sets available for the Roche Diabetes Care products would not suitably fit into the same RTP. These products were therefore separated into 2 figures. So, data from 3 to 15 different reagent system lots were displayed in each RTP. Information about the respective SMBG systems and reagent system lots can be found in Table 1 .
The RTPs are displayed in Figures 1 to 9. The figures are composed of 2 parts. The larger, upper part shows the rectangles calculated from the measurement data. In the smaller, lower part, the mean absolute and relative differences (ie, the center of the rectangle) are indicated for each individual reagent system lot. Different colors represent reagent system lots showing a certain percentage of differences between system measurements and comparison measurements within the system accuracy limits as defined in ISO 15197:2013 or within and outside the system accuracy limits as defined in ISO 15197:2003. The dark green rectangles represent tolerance intervals for test strip lots that meet stringent criteria of ±10 mg/dL/±10% for system accuracy. The light green rectangles represent tolerance intervals for test strip lots that meet the ±15 mg/dL/±15% system accuracy limits as stipulated by ISO 15197:2013 (criterion A). The orange rectangles show tolerance intervals for test strip lots that meet the system accuracy criteria of ISO 15197:2003, but not ISO 15197:2013. The red rectangles show tolerance intervals for test strip lots that do not meet the system accuracy criteria of either ISO 15197:2013 or ISO 15197:2003.
Because of the statistical methods used in the RTP approach, it is not intended to be a substitute for a system accuracy assessment following ISO 15197. Although there is a high degree of consistency between compliance with ISO 15197:2013 criterion A and having a rectangle within the light grey area (±15 mg/dL/±15%), the RTP is a predictor for a system's measurement performance, but does not provide a definitive statement regarding ISO 15197.
The RTP approach was suitable for 81 of the 87 reagent system lots analyzed. For the remaining 6 reagent system lots, the measurement data showed a pronounced deviation from normal distribution due to excessive skewness. In these cases, the rectangles were calculated using robust estimators but marked with dashed lines as the size of the rectangles may not fully correspond to real assessment data. Thus, the RTP was fully applicable in more than 93% of cases analyzed. In the remaining 7% of cases, the calculated rectangles rather overestimated the real performance of the respective SMBG systems.
Discussion
Common approaches to graphical presentations such as difference plots and regression plots display each data point separately. The disadvantage of such plots is that they become difficult to comprehend as the number of data points displayed increases.
The RTP is a method of visualizing a large amount of measurement accuracy data from an SMBG system graphically as a single rectangle, thus facilitating a comprehensible display of system accuracy data from multiple reagent system lots or products in the same graph.
In the analysis presented here, the RTP approach was suitable for nearly all analytical accuracy data sets considered. The results of the analysis suggest that RTPs can be used to Figure 1. Rectangle target plots (RTPs) for SMBG systems from Abbott Diabetes Care. Different colors stand for reagent system lots showing a certain percentage of differences between system measurements and comparison measurements within specified limits. Dark green: ≥95% of differences within ±10 mg/dL and ±10% at glucose concentrations <100 mg/dL and ≥100 mg/dL, respectively. Light green: ≥95% of differences within ±15 mg/dL and ±15% at glucose concentrations <100 mg/dL and ≥100 mg/dL, respectively. Yellow: ≥95% of differences within ±15 mg/dL and ±20% at glucose concentrations <75 mg/dL and ≥75 mg/dL, respectively. Red: <95% of differences within ±15 mg/dL and ±20% at glucose concentrations <75 mg/dL and ≥75 mg/dL, respectively. See also Table 1 . Rectangles plotted in dashed lines mark reagent system lots where tolerance intervals are inconsistent with the distribution of results.
illustrate the analytical accuracy of a broad variety of SMBG systems and test strip lots. Therefore, the RTP approach allows for an easy comparison of reagent systems within and among manufacturers.
The size and location of the rectangles in the figures clearly show whether different products or different reagent system lots of the same product have consistent analytical accuracy. As described by Stephan and colleagues, 11 the size of the rectangle illustrates the measurement variability, and the center of the rectangle indicates the mean bias of the reagent system lot separately for the low and the high glucose concentration range relative to comparison method results. Small, centered rectangles represent better performance than large rectangles or rectangles positioned away from the center of the graph.
The graphs presented in Figures 1 to 9 show clearly different performance characteristics of SMBG systems per manufacturer. The RTPs suggest a wide variety in performance between manufacturers resulting from the observed level of heterogeneity of the rectangles. Comparisons of different products from the same or different manufacturers might help to estimate the effect of switching from 1 product to another. However, it should be borne in mind that this analysis was performed based on the data sets available to the authors and does not make a claim to completeness with respect to the respective manufacturers' portfolios.
Some products for which multiple reagent system lots were tested exhibit only small lot-to-lot variation, whereas other products exhibit greater lot-to-lot variation. Lot-to-lot variation for a specific product is of direct relevance to the reliability of BG measurement results obtained by persons with diabetes. Since BG results are used by insulin-dependent persons with diabetes to adjust their diabetes therapy, the reliability of the measurement results is of great importance with regard to short-term and long-term complications. 15 Data sets used to illustrate the RTP approach in this article were obtained in evaluations assessing the system accuracy of SMBG systems following ISO 15197. Although the RTPs include shaded areas and color coding related to the system accuracy criteria of ISO 15197, the RTP approach is not intended to replace the analysis recommended in ISO 15197, and it is not limited to data sets obtained in this kind of accuracy evaluation.
Conclusions
In conclusion, the RTP approach allowed the analytical accuracy data of reagent system lots from different SMBG system manufacturers to be visualized in a comprehensible manner. Accuracy results were used to assess the consistency among reagent system lots for specific SMBG systems and the consistency among products of the same manufacturer. In both cases, qualitative differences could easily be identified using the RTP.
